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The Crisis of Opiates in Appalachia 
 
The opiate abuse crisis gripping the Appalachian region is one of the most challenging health 
issues of our time. Serious consequences resulting from this problem are of staggering 
proportions.  While overdose deaths and crime lead the headlines, other consequences are 
equally concerning. The number of children born exposed to opiates has skyrocketed, and we 
have yet to understand the long-term consequences. Hepatitis rates have exploded due to 
intravenous drug use. Young adults with felony drug convictions can’t find employment.  This 
problem has shredded the family structure in our communities. This is a frightening reality. 
Although the opiate crisis is not new to Appalachia, it is evolving in a dangerous ways such as 
the introduction of black tar heroin in our region. An excellent account of the socioeconomic 
factors driving this devastating social phenomenon is well described in “Dreamland, the True 
Tale of America’s Opiate Epidemic” by Sam Quinones: a book I strongly recommend. Quinones 
traces the introduction of heroin by Mexican growers to the Appalachian region and explores the 
complex social and economic factors that account for the problems explosive expansion. 
Addiction is one of the most challenging health conditions to manage. The problem’s 
complications include the combination of physical and mental health diagnoses that interact with 
social factors, leading vulnerable individuals to self-medicate with narcotics. It is common for 
addicts to have experienced traumatic life events. Many have histories of criminal activity. Even 
if treatment addresses all of these factors driving the addiction, a patient may move toward 
recovery, fail, and relapse into drug use again, and then recycle through the treatment programs.  
The deadly cycle often repeats time and again.  Unlike most medical conditions that can be cured 
or, at least stabilized, addiction frequently runs out of control with devastating impact on addicts, 
families and communities. Addiction medicine treatment specialists recognize the instability of 
the condition and learn to accept small successes. For the addicted patient, success may be as 
simple as 3 months being drug free, reconnecting with family, or having stable housing. It is a 
difficult and tragic life. 
In the 1960s and 70s, America confronted heroin addiction in soldiers returning from the 
Vietnam War. One of the responses to this address this problem was the War on Drugs and the 
adoption of medication-assisted treatment (MAT) programs.  These were primarily based on 
using methadone as a maintenance medication. Studies performed in those years demonstrated 
that, for individuals with refractory opiate dependence, maintenance with daily methadone could 
enable the patient to maintain employment and fully engage in society. Today, MAT continues to 
be a mainstay of treatment programs aimed at managing addiction. Contemporary treatment 
programs rely on a variety of medications including methadone, buprenorphine/naloxone 
combinations, or naltrexone. Many questions concerning this treatment approach remain unasked 
and unanswered.  Which patients are most appropriate for MAT with which medication?  What 
criteria should guide the choice of this therapy? Is MAT a life-long treatment approach? Would 
MAT treatment be effective in rural settings where limited employment options are an additional 
complication? 
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Decades ago “abstinence programs” emerged as a treatment for alcohol abuse. These became 
known as “12-step” or Alcoholics Anonymous (AA) programs. Today, excellent abstinence 
programs for narcotics represent another important option for the treatment of opiate addiction. 
These programs frequently offer peer-support and assistance in dealing with the myriad social 
consequences of addiction. These programs are available to addicts without cost and they are 
voluntary and anonymous, a fact that has limited the opportunity to collect data on effectiveness 
in reducing addictive behavior.   
In addition to treatment programs, other approaches have been implemented to reduce the impact 
of adverse health effects resulting from opiate abuse. “Harm reduction” efforts in the form of 
naloxone programs and needle exchanges are being created in many county Health Departments.  
These programs can help to reduce overdose deaths and the spread of viral hepatitis and HIV. 
Health Departments also offer a hepatitis B vaccine for people at high risk due to IV drug use. 
When providers work with drug-addicted patients they often discover gaps in the evidence-based 
findings that should guide the management of opiate addiction. There are clinical guidelines 
from the Substance Abuse and Mental Health Services Administration and the National Institute 
on Drug Abuse. A comprehensive look at substance use disorder and its treatment was published 
in 2014 by The Institute for Clinical and Economic Review. This comparative effectiveness 
review outlines the evidence for treatment approaches in substance use disorder. It is an 
important read for providers and policymakers as they tackle this crisis.  Despite the availability 
of these excellent resources many important questions remain to be explored, especially in select 
population and situations. In my opinion the significance of the opiate crisis in Appalachia 
establishes an important opportunity, perhaps an obligation, to engage in further systematic 
studies of the phenomenon of addiction in rural populations. 
James Becker, MD 
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